{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:19:37Z","timestamp":1788261577047,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76326-5","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:25:59Z","timestamp":1785759959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Large language models decode narrative pathology reports to define clinically relevant subtypes in IgA nephropathy"],"prefix":"10.1038","volume":"17","author":[{"given":"Ji","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongxiu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqiu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaosheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-302X","authenticated-orcid":false,"given":"Min","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"76326_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.kint.2025.01.014","volume":"107","author":"J Floege","year":"2025","unstructured":"Floege, J., Bernier-Jean, A., Barratt, J. & Rovin, B. Treatment of patients with IgA nephropathy: a call for a new paradigm. Kidney Int. 107, 640\u2013651 (2025).","journal-title":"Kidney Int."},{"key":"76326_CR2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/jamainternmed.2019.0600","volume":"179","author":"SJ Barbour","year":"2019","unstructured":"Barbour, S. J. et al. Evaluating a new international risk-prediction tool in IgA nephropathy. JAMA Intern. Med. 179, 942\u2013952 (2019).","journal-title":"JAMA Intern. Med."},{"key":"76326_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin, B. H. et al. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1\u2013S276 (2021).","journal-title":"Kidney Int."},{"key":"76326_CR4","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1016\/j.ekir.2023.09.020","volume":"8","author":"DC Cattran","year":"2023","unstructured":"Cattran, D. C., Floege, J. & Coppo, R. Evaluating progression risk in patients with immunoglobulin A nephropathy. Kidney Int. Rep. 8, 2515\u20132528 (2023).","journal-title":"Kidney Int. Rep."},{"key":"76326_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"Working Group of the International","year":"2009","unstructured":"Working Group of the International IgAN et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 76, 534\u2013545 (2009).","journal-title":"Kidney Int."},{"key":"76326_CR6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ki.2009.168","volume":"76","author":"IS Roberts","year":"2009","unstructured":"Roberts, I. S. et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 76, 546\u2013556 (2009).","journal-title":"Kidney Int."},{"key":"76326_CR7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi, H. et al. Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 91, 1014\u20131021 (2017).","journal-title":"Kidney Int."},{"key":"76326_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0046-8177(82)80221-9","volume":"13","author":"SM Lee","year":"1982","unstructured":"Lee, S. M. IgA nephropathy: morphologic predictors of progressive renal disease. Hum. Pathol. 13, 314\u2013322 (1982).","journal-title":"Hum. Pathol."},{"key":"76326_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0272-6386(97)90456-X","volume":"29","author":"M Haas","year":"1997","unstructured":"Haas, M. Histologic subclassification of IgA nephropathy a clinicopathologic study of 244 cases. Am. J. Kidney Dis. 29, 829\u2013842 (1997).","journal-title":"Am. J. Kidney Dis."},{"key":"76326_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0272-6386(97)90472-8","volume":"29","author":"Lee SM. Kurt","year":"1997","unstructured":"SM. Kurt, L. ee Prognostic indicators of progressive renal disease in IgA nephropathy emergence of a new histologic grading system. Am. J. Kidney Dis. 29, 953\u2013958 (1997).","journal-title":"Am. J. Kidney Dis."},{"key":"76326_CR11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2017.9362","volume":"318","author":"J Lv","year":"2017","unstructured":"Lv, J. et al. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING Randomized Clinical Trial. JAMA 318, 432\u2013442 (2017).","journal-title":"JAMA"},{"key":"76326_CR12","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","volume":"373","author":"T Rauen","year":"2015","unstructured":"Rauen, T. et al. Intensive supportive care plus Immunosuppression in IgA nephropathy. N. Engl. J. Med. 373, 2225\u20132236 (2015).","journal-title":"N. Engl. J. Med."},{"key":"76326_CR13","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.kint.2020.04.046","volume":"98","author":"T Rauen","year":"2020","unstructured":"Rauen, T. et al. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. Kidney Int. 98, 1044\u20131052 (2020).","journal-title":"Kidney Int."},{"key":"76326_CR14","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/jama.2022.5368","volume":"327","author":"J Lv","year":"2022","unstructured":"Lv, J. et al. Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING Randomized Clinical Trial. JAMA 327, 1888\u20131898 (2022).","journal-title":"JAMA"},{"key":"76326_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/nep.14369","volume":"29","author":"P Chen","year":"2024","unstructured":"Chen, P. & Lv, J. Low-dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy, an update of current clinical trials. Nephrology (Carlton) 29, 25\u201329 (2024).","journal-title":"Nephrology (Carlton)"},{"key":"76326_CR16","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/ndt\/gfw286","volume":"31","author":"T Rauen","year":"2016","unstructured":"Rauen, T., Eitner, F., Fitzner, C. & Floege, J. Con: STOP immunosuppression in IgA nephropathy. Nephrol. Dial. Transplant. 31, 1771\u20131774 (2016).","journal-title":"Nephrol. Dial. Transplant."},{"key":"76326_CR17","first-page":"992","volume":"374","author":"FP Schena","year":"2016","unstructured":"Schena, F. P. & Manno, C. Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med 374, 992 (2016).","journal-title":"N Engl J Med"},{"key":"76326_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin, B. H. et al. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney Int. 100, 753\u2013779 (2021).","journal-title":"Kidney Int."},{"key":"76326_CR19","doi-asserted-by":"publisher","first-page":"e64544","DOI":"10.2196\/64544","volume":"9","author":"D Lee","year":"2025","unstructured":"Lee, D. et al. Using large language models to automate data extraction from surgical pathology reports: retrospective cohort study. JMIR Form Res. 9, e64544 (2025).","journal-title":"JMIR Form Res."},{"key":"76326_CR20","doi-asserted-by":"publisher","unstructured":"Di Palma, L., Darvizeh, F., Al\u00ec, M. & Fazzini, D. Structured transformation of unstructured prostate MRI reports using large language models. Tomography 11 https:\/\/doi.org\/10.3390\/tomography11060069 (2025).","DOI":"10.3390\/tomography11060069"},{"key":"76326_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/2056-4538.70010","volume":"10","author":"E Alzaid","year":"2024","unstructured":"Alzaid, E., Pergola, G., Evans, H., Snead, D. & Minhas, F. Large multimodal model-based standardisation of pathology reports with confidence and its prognostic significance. J .Pathol. Clin. Res. 10, e70010 (2024).","journal-title":"J .Pathol. Clin. Res."},{"key":"76326_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3857\/roj.2023.00633","volume":"41","author":"HS Choi","year":"2023","unstructured":"Choi, H. S., Song, J. Y., Shin, K. H., Chang, J. H. & Jang, B. S. Developing prompts from a large language model for extracting clinical information from pathology and ultrasound reports in breast cancer. Radiat. Oncol. J. 41, 209\u2013216 (2023).","journal-title":"Radiat. Oncol. J."},{"key":"76326_CR23","doi-asserted-by":"publisher","first-page":"e73603","DOI":"10.2196\/73603","volume":"27","author":"M Toal","year":"2025","unstructured":"Toal, M., Hill, C., Quinn, M., O\u2019Neill, C. & Maxwell, A. P. Large language models\u2019 clinical decision-making on when to perform a kidney biopsy: comparative study. J. Med. Internet Res. 27, e73603 (2025).","journal-title":"J. Med. Internet Res."},{"key":"76326_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-025-01131-z","volume":"32","author":"U Iqbal","year":"2025","unstructured":"Iqbal, U. et al. Impact of large language model (ChatGPT) in healthcare: an umbrella review and evidence synthesis. J. Biomed. Sci. 32, 45 (2025).","journal-title":"J. Biomed. Sci."},{"key":"76326_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41746-025-02009-y","volume":"8","author":"I Luo","year":"2025","unstructured":"Luo, I. et al. Leveraging large language models to extract smoking history from clinical notes for lung cancer surveillance. NPJ Digit. Med. 8, 731 (2025).","journal-title":"NPJ Digit. Med."},{"key":"76326_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MNH.0000000000000312","volume":"26","author":"MF Soares","year":"2017","unstructured":"Soares, M. F. & Roberts, I. S. IgA nephropathy: an update. Curr. Opin. Nephrol. Hypertens. 26, 165\u2013171 (2017).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"76326_CR27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.ajkd.2013.04.021","volume":"62","author":"J Lv","year":"2013","unstructured":"Lv, J. et al. Evaluation of the Oxford classification of IgA nephropathy: a systematic review and meta-analysis. Am. J. Kidney Dis. 62, 891\u2013899 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"76326_CR28","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2014.63","volume":"86","author":"R Coppo","year":"2014","unstructured":"Coppo, R. et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 86, 828\u2013836 (2014).","journal-title":"Kidney Int."},{"key":"76326_CR29","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.kint.2024.03.011","volume":"105","author":"SS Bellur","year":"2024","unstructured":"Bellur, S. S., Troyanov, S., Vorobyeva, O., Coppo, R. & Roberts, I. S. D. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy. Kidney Int. 105, 1279\u20131290 (2024).","journal-title":"Kidney Int."},{"key":"76326_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.34067\/KID.0000000000000195","volume":"4","author":"AJ Howie","year":"2023","unstructured":"Howie, A. J. & Lalayiannis, A. D. Systematic review of the Oxford classification of IgA nephropathy: reproducibility and prognostic value. Kidney360 4, 1103\u20131111 (2023).","journal-title":"Kidney360"},{"key":"76326_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrneph.2014.92","volume":"10","author":"IS Roberts","year":"2014","unstructured":"Roberts, I. S. Pathology of IgA nephropathy. Nat. Rev. Nephrol. 10, 445\u2013454 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"76326_CR32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ckj\/sfy093","volume":"12","author":"AJ Rankin","year":"2019","unstructured":"Rankin, A. J. et al. Assessment of active tubulointerstitial nephritis in non-scarred renal cortex improves prediction of renal outcomes in patients with IgA nephropathy. Clin. Kidney J. 12, 348\u2013354 (2019).","journal-title":"Clin. Kidney J."},{"key":"76326_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.kint.2025.04.003","volume":"108","author":"J Floege","year":"2025","unstructured":"Floege, J. et al. Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV). Kidney Int. 108, 548\u2013554 (2025).","journal-title":"Kidney Int."},{"key":"76326_CR34","first-page":"44","volume":"157","author":"HT Cook","year":"2007","unstructured":"Cook, H. T. Interpretation of renal biopsies in IgA nephropathy. Contrib. Nephrol. 157, 44\u201349 (2007).","journal-title":"Contrib. Nephrol."},{"key":"76326_CR35","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1053\/j.ajkd.2016.11.027","volume":"69","author":"JH Hou","year":"2017","unstructured":"Hou, J. H. et al. Mycophenolate mofetil combined with prednisone versus full-dose prednisone in IgA nephropathy with active proliferative lesions: a randomized controlled trial. Am. J. Kidney Dis. 69, 788\u2013795 (2017).","journal-title":"Am. J. Kidney Dis."},{"key":"76326_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00281-020-00827-8","volume":"42","author":"A Shimba","year":"2020","unstructured":"Shimba, A. & Ikuta, K. Control of immunity by glucocorticoids in health and disease. Semin. Immunopathol. 42, 669\u2013680 (2020).","journal-title":"Semin. Immunopathol."},{"key":"76326_CR37","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3389\/fimmu.2019.02028","volume":"10","author":"JM Ehrchen","year":"2019","unstructured":"Ehrchen, J. M., Roth, J. & Barczyk-Kahlert, K. More than suppression: glucocorticoid action on monocytes and macrophages. Front. Immunol. 10, 2028 (2019).","journal-title":"Front. Immunol."},{"key":"76326_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain, D. W. & Cidlowski, J. A. Immune regulation by glucocorticoids. Nat. Rev. Immunol. 17, 233\u2013247 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"76326_CR39","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1007\/s00330-024-11074-y","volume":"35","author":"P Wo\u017anicki","year":"2025","unstructured":"Wo\u017anicki, P. et al. Automatic structuring of radiology reports with on-premise open-source large language models. Eur. Radiol. 35, 2018\u20132029 (2025).","journal-title":"Eur. Radiol."},{"key":"76326_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41586-025-09422-z","volume":"645","author":"D Guo","year":"2025","unstructured":"Guo, D. et al. DeepSeek-R1 incentivizes reasoning in LLMs through reinforcement learning. Nature 645, 633\u2013638 (2025).","journal-title":"Nature"},{"key":"76326_CR41","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. Qwen3 embedding: advancing text embedding and reranking through foundation models. Preprint at arXiv https:\/\/doi.org\/10.48550\/arXiv.2506.05176 (2025).","DOI":"10.48550\/arXiv.2506.05176"},{"key":"76326_CR42","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"76326_CR43","unstructured":"Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. Advances in neural information processing systems 30 (2017)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76326-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76326-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76326-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:02:21Z","timestamp":1788260541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76326-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76326"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76326-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9328"}}